Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The relevance of animal models in multiple sclerosis research.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment.
IL-17 and Th17 Cells.
Therapeutic plasma exchange and pregnancy: A case report and guidelines for performing plasma exchange in a pregnant patient.
Clinically isolated syndrome - Rethinking the diagnosis.
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis.
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
The neuroendocrine axis in patients with multiple sclerosis.
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis.
Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
Sex differences in autoimmune diseases.
Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID).
T(H)17 cytokines in autoimmune neuro-inflammation.
Suppressed RNA-Polymerase 1 Pathway Is Associated with Benign Multiple Sclerosis.
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort.

Pages